Armstrong supports Connection Capital’s investment in MatOrtho
Armstrong has provided CDD support as Connection Capital’s clients invest in MatOrtho. Founded in 2010, MatOrtho designs, manufactures and commercialises performance leading, orthopaedic implant devices. It is one of the UK’s most innovative orthopaedic device designers. The company has achieved strong growth and has built a truly global presence, supplying implant devices into many of the world’s orthopaedic markets.
MatOrtho’s mission is improving the quality of life of all patients who receive one of its devices. Based in Leatherhead, the company has an international reputation for technical innovation. Its range of advanced knee, hip, and finger replacement procedures consistently deliver clinically proven, best-in-class patient outcomes for implant performance and sustained use with better patient satisfaction. The private equity investment will enable MatOrtho to accelerate international expansion into new and existing markets and will support research and development as the company continues to develop the next generation of implant technology.
Armstrong provided buy-side CDD, including in-depth interviews with customers and market participants in the UK, Australia, Germany, and South Africa. As a result, Armstrong delivered clear and evidence-based conclusions and recommendations as to market drivers and developments, and growth opportunities for MatOrtho.
Michael Coupland at Connection said “Armstrong provided valuable insight in relation to our investment in MatOrtho. The feedback they obtained from the customer base has been really helpful and has informed our view on strategic priorities and initiatives as there is an increased understanding of what our customers want. We thank Peter and the wider team for their support and look forward to working together in the future.”
To find out Armstrong’s views on opportunities in the healthcare sector, please contact;
Peter Cookson, PartnerEmail Peter
Roma Dixit, Senior ConsultantEmail Roma